98%
921
2 minutes
20
Objective: The objective is to evaluate the surgical outcomes of partial atlas transverse process resection, with or without additional release and perfusion techniques, in the treatment of internal jugular vein stenosis from external compression.
Methods: A retrospective cohort study was conducted on patients who underwent surgery from January 2020 to September 2022 and had J3 segment stenosis of the internal jugular vein (IJV) owing to osseous compression. CT venography (CTV), contrast-enhanced magnetic resonance angiography (CE-MRA), and Doppler ultrasonography were incorporated into the preoperative and postoperative evaluations at 1 week and 3 months to measure the diameter of the IJV and hemodynamic parameters. A visual analog scale (VAS) was employed to quantify the severity of symptoms. The outcomes of two surgical approaches were compared: isolated lateral partial atlas transverse process resection (isolated group, n=15) and combined resection with release and perfusion techniques (combined group, n=32).
Results: The treatment group exhibited substantially superior outcomes at the 1-week follow-up among 47 patients (mean age 52.53±13.76, including 24 males): In the treatment group, the symptom improvement rate was 62.5% (20 out of 32 patients), while in the control group, it was 20% (3 out of 15 patients). In the treatment group, 84.3% (27 out of 32 patients) of patients experienced stenosis alleviation, while 46.67% (7 out of 15 patients) of patients in the control group did. The control group demonstrated improvement in 40.0% (6 out of 15 patients), while the treatment group demonstrated hemodynamic improvement in 75.0% (24 out of 32 patients). All results were statistically significant (p<0.05). The treatment group (20%) and the control group (12.5%, p=0.815) were not significantly different in terms of complication rates during the 3-month follow-up.
Conclusion: In comparison to isolated osseous decompression, the combined surgical protocol, which incorporates partial atlas transverse process resection, release, and perfusion techniques, exhibits superior anatomical restoration, hemodynamic recovery, and symptom relief, while maintaining comparable safety profiles.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.wneu.2025.124397 | DOI Listing |
JCI Insight
September 2025
Division of Nephrology, Boston University Chobanian & Avedisian School of Medicine, Boston, United States of America.
Background: Active vitamin D metabolites, including 25-hydroxyvitamin D (25D) and 1,25-dihydroxyvitamin D (1,25D), have potent immunomodulatory effects that attenuate acute kidney injury (AKI) in animal models.
Methods: We conducted a phase 2, randomized, double-blind, multiple-dose, 3-arm clinical trial comparing oral calcifediol (25D), calcitriol (1,25D), and placebo among 150 critically ill adult patients at high-risk of moderate-to-severe AKI. The primary endpoint was a hierarchical composite of death, kidney replacement therapy (KRT), and kidney injury (baseline-adjusted mean change in serum creatinine), each assessed within 7 days following enrollment using a rank-based procedure.
Mol Pharm
September 2025
Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-Ku, Kyoto 606-8501, Japan.
Fibroblast activation protein (FAP) is an attractive biomarker for tumor-targeting radioligands. While [Ga]Ga-FAPI-46 is a promising FAP-targeting radioligand for cancer diagnosis, clinical application of [Lu]Lu-FAPI-46 for targeted radionuclide therapy is limited due to its insufficient tumor retention. Albumin binder (ALB) including 4-(-iodophenyl)butyric acid is widely utilized to improve tumor accumulation of radioligands.
View Article and Find Full Text PDFClin J Am Soc Nephrol
September 2025
Kidney Division, Peking University First Hospital, Peking University Institute of Nephrology; Key Laboratory of Kidney Disease, Ministry of Health of China; Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education, China.
Background: The Therapeutic Effects of Steroids in IgA Nephropathy Global (TESTING) trial demonstrated that glucocorticoid therapy reduced proteinuria and improved kidney outcomes in patients with Immunoglobulin A Nephropathy (IgAN). Galactose-deficient IgA1 (Gd-IgA1) plays a central role in IgAN pathogenesis by promoting immune complex formation. However, the effects of glucocorticoid on pathogenic IgA levels remain unclear.
View Article and Find Full Text PDFNeurol Res
September 2025
Zeenat Qureshi Stroke Institute and Department of Neurology, University of Missouri, Columbia, MO, USA.
Background: The benefits of rehabilitation in acute ischemic stroke patients following thrombectomy remain underexplored. We assessed which activities of daily living (ADLs) show the greatest improvement after goal-directed therapy in an inpatient rehabilitation setting.
Methods: We retrospectively analyzed pre- and post-rehabilitation functional assessments in 40 acute ischemic stroke patients treated with mechanical thrombectomy.
J Med Internet Res
September 2025
Institute of Social Medicine, Occupational Health and Public Health (ISAP), Medical Faculty, University of Leipzig, Leipzig, Germany.
Background: The loss of a loved one is a common yet stressful event in later life. Internet- and mobile-based interventions have been proposed as an effective treatment approach for individuals with prolonged grief.
Objective: The AgE-health study aimed to investigate the efficacy of an eHealth intervention, trauer@ktiv, in reducing prolonged grief symptoms in a sample of older adults.